![Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/abc9c9cb28e5293cdf9a9687c3a5a9f40dfb7897-427x220.gif?fit=crop&auto=format)
Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer
![PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e7d901374eddb6500e1e3f83e8039d512de691b3/2-Table1-1.png)
PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar
![VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer | 2 Minute Medicine VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2021/01/2MM-VA-1.3.2021_2_Capecitabine_Observation_TNBC-scaled.jpg)
VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer | 2 Minute Medicine
![Seven-day capecitabine plus docetaxel and oxaliplatin regimen for the treatment of advanced gastric cancer: A phase-I clinical trial Seven-day capecitabine plus docetaxel and oxaliplatin regimen for the treatment of advanced gastric cancer: A phase-I clinical trial](https://www.spandidos-publications.com/article_images/mco/6/4/mco-06-04-0622-g00.jpg)
Seven-day capecitabine plus docetaxel and oxaliplatin regimen for the treatment of advanced gastric cancer: A phase-I clinical trial
A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring--supporting patients in their homes - Document - Gale OneFile: Health and Medicine
![Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial - ScienceDirect Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419346836-gr1.jpg)
Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial - ScienceDirect
![Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial | Anticancer Research Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/42/5/2683/F1.large.jpg)
Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial | Anticancer Research
![Capecitabine and Docetaxel Combination for the Treatment of Breast Cancer - Mariko Morishita, Robert C Leonard, 2008 Capecitabine and Docetaxel Combination for the Treatment of Breast Cancer - Mariko Morishita, Robert C Leonard, 2008](https://journals.sagepub.com/cms/10.2217/17455057.4.1.11/asset/images/large/10.2217_17455057.4.1.11-fig1.jpeg)
Capecitabine and Docetaxel Combination for the Treatment of Breast Cancer - Mariko Morishita, Robert C Leonard, 2008
![Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer – topic of research paper in Clinical Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer – topic of research paper in Clinical](https://cyberleninka.org/viewer_images/1282337/f/1.png)
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer – topic of research paper in Clinical
![Capecitabine as Salvage Therapy for a Pancreatic Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function Capecitabine as Salvage Therapy for a Pancreatic Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function](https://www.primescholars.com/articles-images/pancreas-9-3-3-t001.png)